Literature DB >> 3861193

Acute myeloid leukaemia after treatment with razoxane.

E A Caffrey, M G Daker, J J Horton.   

Abstract

Two new cases of acute myeloid leukaemia occurring after razoxane therapy are recorded and further haematological and cytogenetic details of two cases previously reported are described. The need for long-term follow-up after patients discontinue razoxane therapy is emphasized.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861193     DOI: 10.1111/j.1365-2133.1985.tb02054.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  1 in total

1.  Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.

Authors:  Takahiro Okamoto; Masaya Okada; Takeshi Wakae; Ako Mori; Hiroyuki Takatsuka; Eizo Kakishita
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.